Discontinue Methyldopa Permanently and Seek Neurological Evaluation
You should immediately stop methyldopa permanently and consult a neurologist for evaluation of your Alice in Wonderland Syndrome (AIWS) and persistent neurological symptoms. The head and facial pressure/pain you're experiencing 4 days after stopping the medication represents ongoing neurological effects that require medical assessment.
Why Methyldopa Must Be Avoided
Methyldopa causes significant central nervous system effects that are particularly relevant to your situation:
- Neuropsychiatric effects are well-documented: The FDA label explicitly lists "symptoms of cerebrovascular insufficiency, psychic disturbances including nightmares and reversible mild psychoses or depression, headache, sedation, dizziness, paresthesias" as adverse reactions 1
- CNS penetration is the mechanism: Methyldopa works by stimulating alpha-adrenergic receptors in cardiovascular control centers in the brain 2, making neurological side effects inherent to its action
- Your symptoms indicate CNS sensitivity: Triggering AIWS with just 62 mg (1/4 of a 250 mg tablet) demonstrates marked sensitivity to methyldopa's central effects
What Your Persistent Symptoms Mean
The head and facial pressure/pain occurring when falling asleep and upon waking 4 days after discontinuation suggests:
- Delayed clearance or prolonged effects: While methyldopa typically has a "relatively short duration of action" with hypertension returning within 48 hours of withdrawal 1, neurological effects may persist longer
- Possible kindling or sensitization: Your brain may have been sensitized to migraine-like phenomena
- Not typical withdrawal: The FDA label notes withdrawal is "not complicated by an overshoot" 1, so these symptoms represent adverse effects rather than rebound
Immediate Management Steps
- Do not take any more methyldopa - even partial doses
- Document your symptoms: Track the timing, severity, and characteristics of the head/facial pressure
- Seek neurological evaluation within 1-2 days to assess for:
- Migraine aura variants (AIWS can be a migraine aura manifestation)
- Need for acute migraine treatment if symptoms represent ongoing attacks
- Exclusion of other neurological causes
If You Need Blood Pressure Treatment
Should you require antihypertensive therapy, avoid methyldopa entirely and discuss alternatives with your physician:
- Beta-blockers (metoprolol, propranolol) are first-line for both hypertension and migraine prevention 3
- These would address both conditions if you develop recurrent migraine
- Methyldopa should be documented as causing adverse neurological reactions in your medical record
Common Pitfalls to Avoid
- Do not restart methyldopa "to see if it happens again" - you've already demonstrated sensitivity
- Do not assume symptoms will resolve on their own - persistent neurological symptoms 4 days post-discontinuation warrant evaluation
- Do not delay seeking care - while methyldopa's neuropsychiatric effects are typically "reversible" 1, you need assessment to ensure resolution and rule out other causes
The combination of AIWS triggering and persistent neurological symptoms indicates you should never receive methyldopa again, and your current symptoms require prompt medical evaluation to ensure appropriate management and symptom resolution.